Loading viewer...
investor_presentation
Format: PDF investor_presentation
CohBar's March 2020 investor update outlines the therapeutic potential of mitochondrial peptides and provides insights into ongoing clinical trials and future strategies.
investor_presentation
10 Pages
Marvell Technology